Factors associated with the use of potentially inappropriate medications by older adults with cancer

Maggiore, 2014, Polypharmacy and potentially inappropriate medication use in older adults with cancer undergoing chemotherapy: effect on chemotherapy-related toxicity and hospitalization during treatment, J Am Geriatr Soc, 62, 1505, 10.1111/jgs.12942 He, 2011, Clinical pharmacology of chemotherapy agents in older people with cancer, Curr Gerontol Geriatr Res, 628670 National Comprehensive Cancer Network Turner, 2014, Prevalence and factors associated with polypharmacy in older people with cancer, Support Care Cancer, 22, 1727, 10.1007/s00520-014-2171-x Sharma, 2016, Polypharmacy and potentially inappropriate medication use in geriatric oncology, J Geriatr Oncol, 7, 346, 10.1016/j.jgo.2016.07.010 Lichtman, 2015, Polypharmacy: geriatric oncology evaluation should become mainstream, J Clin Oncol, 33, 1422, 10.1200/JCO.2014.60.3548 Saarelainen, 2014, Potential inappropriate medication use in older people with cancer: prevalence and correlates, J Geriatr Oncol, 5, 439, 10.1016/j.jgo.2014.07.001 Lees, 2011, Polypharmacy in elderly patients with cancer: clinical implications and management, Lancet Oncol, 12, 1249, 10.1016/S1470-2045(11)70040-7 American Geriatrics Society, 2015, Beers Criteria Update Expert Panel. American Geriatrics Society 2015 updated Beers Criteria for potentially inappropriate medication use in older adults, J Am Geriatr Soc, 63, 2227, 10.1111/jgs.13702 O'Mahony, 2015, STOPP/START criteria for potentially inappropriate prescribing in older people: version 2, Age Ageing, 44, 213, 10.1093/ageing/afu145 Prithviraj, 2012, Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer, J Geriatr Oncol, 3, 228, 10.1016/j.jgo.2012.02.005 Flood, 2009, Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit, Am J Geriatr Pharmacother, 7, 151, 10.1016/j.amjopharm.2009.05.002 Nightingale, 2015, Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer, J Clin Oncol, 33, 1453, 10.1200/JCO.2014.58.7550 Park, 2016, Effect of polypharmacy and potentially inappropriate medications on treatment and posttreatment courses in elderly patients with head and neck cancer, J Cancer Res Clin Oncol, 142, 1031, 10.1007/s00432-015-2108-x Turner, 2016, Polypharmacy cut-points in older people with cancer: how many medications are too many?, Support Care Cancer, 24, 1831, 10.1007/s00520-015-2970-8 Whitman, 2016, A comprehensive look at polypharmacy and medication screening tools for the older cancer patient, Oncologist, 21, 723, 10.1634/theoncologist.2015-0492 WHO Augschoell, 2014, PPT and VES-13 in elderly patients with cancer: evaluation in multidimensional geriatric assessment and prediction of survival, J Geriatr Oncol, 5, 415, 10.1016/j.jgo.2014.08.005 United Nation. World population ageing. Available at: http://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2013.pdf (Accessed 27 February) 2016. Veehof, 2000, The development of polypharmacy. A longitudinal study, Fam Pract, 17, 261, 10.1093/fampra/17.3.261 Kenis, 2013, Relevance of a systematic geriatric screening and assessment in older patients with cancer: results of a prospective multicentric study, Ann Oncol, 24, 1306, 10.1093/annonc/mds619 Abramowitz, 2016, Adverse event reporting for proton pump inhibitor therapy: an overview of systematic reviews, Otolaryngol Head Neck Surg, 155, 547, 10.1177/0194599816648298 Ito, 2010, Association of long-term proton pump inhibitor therapy with bone fratures and effects on absorption of calcium, vitamin B12, iron, and magnesium, Curr Gastroenterol Rep, 12, 448, 10.1007/s11894-010-0141-0 Gyawali, 2016, Cheaper options in the prevention of chemotherapy-induced nausea and vomiting, J Global Oncol, 2, 145, 10.1200/JGO.2015.002477 Feyer, 2011, Update and new trends in antiemetic therapy: the continuing need for novel therapies, Ann Oncol, 22, 30, 10.1093/annonc/mdq600 Gage, 2014, Benzodiazepine use and risk of Alzheimer's disease: case-control study, BMJ, 349, g5205, 10.1136/bmj.g5205 Gregg, 2016, Benzodiazepines and geriatrics: what clinical practice strategies can be used to reduce the inappropriate prescribing?, Rehabil Nurs, 41, 270, 10.1002/rnj.288 Duc, 2017, Predictive factors of depressive symptoms of elderly patients with cancer receiving first-line chemotherapy, Psychooncology, 26, 15, 10.1002/pon.4090 Lichtman, 2014, Geriatric oncology: an overview, J Clin Oncol, 32, 2521, 10.1200/JCO.2014.57.4822